The Use of High Dose Letrozole in Ovulation Induction and Controlled Ovarian HyperstimulationReport as inadecuate




The Use of High Dose Letrozole in Ovulation Induction and Controlled Ovarian Hyperstimulation - Download this document for free, or read online. Document in PDF available to download.

ISRN Obstetrics and GynecologyVolume 2011 2011, Article ID 242864, 4 pages

Clinical StudyWisconsin Fertility Institute, 3146 Deming Way, Middleton, WI 53562, USA

Received 3 September 2011; Accepted 26 September 2011

Academic Editors: C. Castelo-Branco and S. Palomba

Copyright © 2011 Elizabeth A. Pritts et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Letrozole, an aromatase inhibitor, has been demonstrated to be effective as an ovulation induction and controlled ovarian hyperstimulation agent. However, dose administration has generally been limited to 5 days at 2.5 to 7.5 mg daily. We undertook a retrospective review of over 900 treatment cycles using letrozole in doses as high as 12.5 mg per day. Results indicate that such doses do indeed offer benefit to patients; in that there is increased follicular growth and a higher number of predicted ovulations with higher doses of the drug. However, increasing doses does not produce a detrimental effect upon endometrial thickness. High-dose letrozole may be of value in women who fail to respond adequately to lower doses. Furthermore, randomized trials are needed to determine whether high-dose letrozole might actually be optimal as a starting dose for certain treatment groups.





Author: Elizabeth A. Pritts, Alexander K. Yuen, Shefaali Sharma, Robert Genisot, and David L. Olive

Source: https://www.hindawi.com/



DOWNLOAD PDF




Related documents